* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download lactic acid ENG.cdr
Survey
Document related concepts
NADH:ubiquinone oxidoreductase (H+-translocating) wikipedia , lookup
Oxidative phosphorylation wikipedia , lookup
Metalloprotein wikipedia , lookup
Gaseous signaling molecules wikipedia , lookup
Fatty acid metabolism wikipedia , lookup
Microbial metabolism wikipedia , lookup
Basal metabolic rate wikipedia , lookup
Citric acid cycle wikipedia , lookup
Evolution of metal ions in biological systems wikipedia , lookup
Nicotinamide adenine dinucleotide wikipedia , lookup
Biochemistry wikipedia , lookup
Transcript
LABORATORY UPDATE “Pathology that Adds Value” THE PATHCARE NEWS Lactic Acidosis What is lactic acidosis? Lactic acidosis is a high anion gap metabolic acidosis caused by the accumulation of lactic acid, either due to overproduction or underutilization. Lactate homeostasis Lactate is constantly being produced and metabolised in the body. The brain, skin and red blood cells are major sources of lactic acid at rest, whilst skeletal muscle releases significant amounts of lactic acid during exercise. Excess lactate can accumulate when there is increased lactate production and/or diminished lactate utilization (Under 'normal' circumstances the lactate:pyruvate ratio ranges from 4:1 to 10:1). Three mechanisms can underlie the accumulation of lactate: 1. Enhanced pyruvate production. 2. Reduced pyruvate conversion to CO2 and H2O. 3. An altered redox state within the cell during which pyruvate is preferentially converted to lactate. To understand the metabolism of lactate, it is necessary to review the processes of anaerobic and aerobic respiration. The following figure illustrates the basic process: During aerobic respiration there are three steps involved in the oxidation of glucose to carbon dioxide and water: 1. Intracytoplasmic glycolysis, which is the metabolic pathway that converts glucose to pyruvate. 2. Oxygen dependent tricarboxylic acid (TCA) cycle in the mitochondria that converts NADH to NAD+ by means of electron transport. This NAD+ production ceases under anaerobic conditions, resulting in the accumulation of pyruvate and NADH, conditions that favour the production of lactate. 3. Oxygen dependent oxidative phosphorylation in the mitochondria which generates NAD+. January 2013 www.pathcare.co.za LABORATORY UPDATE “Pathology that Adds Value” THE PATHCARE NEWS During anaerobic respiration lactate is derived from the metabolism of pyruvate. This reversible reaction is catalysed by lactate dehydrogenase (LDH), and involves the conversion of NADH to NAD+. When oxygen supply to cells is reduced, NAD+ production by electron transport ceases. This leads to a build-up of both pyruvate and NADH, conditions that favour the production of lactate. What are the causes of lactic acidosis? The causes of lactic acidosis can be divided into two groups: those associated with impaired tissue oxygenation (type A), and those in which systemic impairment of oxygenation is not apparent (type B). Classification Classification of causes of causes ofoflactic lactic acidosis acidosis (Cohen (Cohen & Woods, & Woods, 1976) 1976) Type A lactic acidosis: Clinical evidence of inadequate tissue oxygenation Hypo-perfusion e.g. Cardiogenic-, hypovolemic-, septic-, or haemorrhagic shock or regional ischaemia Tissue hypoxia e.g. Carbon monoxide poisoning, severe asthma and severe anaemia Mechanism: Type A lactic acidosis refers to circumstances where tissue oxygen delivery is inadequate based on clinical assessment. With an adequate supply of oxygen, aerobic tissues regenerate NAD+ via oxidative phosphorylation in the mitochondria. Under anaerobic conditions, tissues regenerate NAD+ in the cytoplasm by converting pyruvate to lactate. NAD+ is essential for glycolysis to continue. Type B lactic acidosis: No clinical evidence of inadequate tissue oxygen delivery Type B1 Associated with acquired diseases e.g. diabetes mellitus (diabetic ketoacidosis - DKA), hepatic failure1, malignancies2, septicaemia, phaeochromocytoma3, post-cardiopulmonary bypass, renal failure, thiamine deficiency4, thyroid storm etc. Associated with metabolites, drugs and toxins e.g. paracetamol, biguanides, cocaine, epinephrine3, norepinephrine3, Type B2 ethanol5, ethylene glycol, isoniazid, lactulose, metformin6, methanol, nalidixic acid, niacin, nitroprusside, nucleoside reverse transcriptase inhibitors (NRTIs)7, paraldehyde, parenteral nutrition4, terbutaline, theophylline etc. Due to inborn errors of metabolism e.g. Glucose-6-phosphate dehydrogenase deficiency, fructose-1,6-diphosphate Type B3 deficiency, pyruvate carboxylase deficiency, organic aciduria, Leigh's disease, Alper's disease and mitochondrial encephalopathies etc. Mechanism: 1. Hepatic Failure – Lactic acidosis due to poor utilization of lactate and altered metabolism; 2. Malignancies – Leukaemia, lymphoma, solid tumours predispose to lactic acidosis; 3. Epinephrine enhances hepatic glycogenolysis and glycolysis to lactate; 4. Fructose in IV fluids and parenteral nutrition leads to thiamine deficiency (co-factor for PDH) and accumulation of lactate; 5. Ethanol oxidation increases the conversion of pyruvate to lactate and decreases the clearance of lactate; 6. Metformin – increases glycolysis in peripheral tissues, decrease pyruvate oxidation and reduces hepatic lactate clearance; 7. NRTIs – drug induced mitochondrial dysfunction Miscellaneous lactic acidosis Spontaneous lactic acidosis Idiopathic lactic acidosis may be due to subclinical, regional hypoperfusion or coexistence of various predisposing conditions or late manifesting enzymatic defect. D-Lactic acidosis Mammalian tissues produce the L-lactate isomer. D-lactate is a metabolic by-product of certain bacteria that may be produced in excess if there is overgrowth of such organisms in the gut (e.g. after jejunal bypass surgery). Laboratory tests will not detect D-lactate since L-LDH is used in the assays. An increased anion gap with normal serum lactate and negative ketones in urine should raise suspicion of a possible D-lactic acidosis. January 2013 www.pathcare.co.za LABORATORY UPDATE “Pathology that Adds Value” THE PATHCARE NEWS Clinical considerations and interpretation With the availability of point-of-care lactate tests, there has been a renewed awareness of lactate as prognostic marker and as an indicator of circulatory impairment in critical care patients. A recent systematic review by Borthwick et al concluded that no specific cut-off value for predicting in-hospital mortality or sequential organ failure can be recommended, since there is a marked overlap between lactate levels of survivors and non-survivors in studies. The most common recommendation across all studies was to use normalisation of blood lactate concentration as a target during goal directed therapy. What are the reference ranges for blood lactate? Plasma Lactate Whole Blood Lactate Arterial reference range 0.5 – 1.6 mmol/L Venous reference range 0.5 – 2.2 mmol/L Specimen Sodium fluoride (grey stopper) tube Heparinised blood gas syringe Note: Plasma and whole blood lactate levels analysed on different instruments in PathCare showed good correlation. It is strongly recommended to use the same specimen type (e.g. arterial/venous) and the same method or instrument for serial lactate measurements. What are the specimen requirements for blood lactate? Venous stasis should be avoided during specimen collection, and the specimen should be analysed without delay. If any delay occurs during specimen collection prior to analysis, the specimen should be kept on ice during that time. Whole blood lactate is available at most laboratories on the blood gas point-of-care analysers, offering a rapid whole blood lactate result. Plasma lactate is usually measured on a central laboratory instrument, blood for plasma lactate should be collected in a sodium fluoride (grey stopper) tube, and transported on ice to the laboratory, for separation of plasma from cells within 15 minutes to prevent false increases in lactate levels (glycolysis continues in vitro). Conclusion: Lactic acidosis is the most common cause of metabolic acidosis in hospitalized patients. Major clues suggesting a diagnosis of lactic acidosis includes: - Increased anion gap, - Increased serum lactate levels, > 4.0 mmol/L (depending on the type of specimen), - ± arterial pH < 7.35 (not always present, especially if a combined acid-base disorder is present). Early identification of lactic acidosis and timely correction of lactic acidosis can improve patient care and outcome. Compiled by: Dr. M. Lloyd, Chemical Pathologist, PathCare, Tel: 051 401 4600, [email protected]. References: 1. Borthwick H, Brunt LK, Mitchem KL, Chaloner C. Does lactate measurement performed on admission predict clinical outcome on the intensive care unit? A concise systematic review. Ann Clin Biochem 2012; 49:391-394. 2. Wu AHB. Tietz clinical guide to laboratory tests 4th ed 2006; 650. 3. Nandwani S, Saluja M, Vats M, Mehta Y. Lactic acidosis in critically ill patients. People's Journal of Scientific Research 2010; 3(1): 43-47. 4. Luft FC. Lactic acidosis update for critical care clinicians. J Am Soc Nephrol 2001; 12:S15-S19. 5. Hancock MR. Mitochondrial dysfunction and the role of the non-specialist laboratory. Ann Clin Biochem 2002; 39:456-463. January 2013 www.pathcare.co.za